Market Cap (In CNY)
7.39 Billion
Revenue (In CNY)
36.41 Billion
Net Income (In CNY)
-1.68 Billion
Avg. Volume
31.08 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.01-3.51
- PE
- -4.33
- EPS
- -0.66
- Beta Value
- 0.445
- ISIN
- CNE000000X95
- CUSIP
- -
- CIK
- -
- Shares
- 2631120000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Feng Zhang
- Employee Count
- -
- Website
- https://www.neptunus.com
- Ipo Date
- 1998-12-18
- Details
- Shenzhen Neptunus Bioengineering Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products primarily in China. It offers drugs in the fields of anti-tumor, cardio-cerebrovascular, marine drugs, and other fields. The company was founded in 1989 and is based in Shenzhen, China.
More Stocks
-
5534
-
4182
-
PNRGPhinergy Ltd.
PNRG
-
0LI9Ubiquiti Inc.
0LI9
-
7486Sanrin Co., Ltd.
7486
-
1338
-
3360
-
UNTUnimot S.A.
UNT